tiprankstipranks
Trending News
More News >
Sino Biopharmaceutical Ltd (HK:1177)
:1177
Hong Kong Market

Sino Biopharmaceutical (1177) Financial Statements

Compare
24 Followers

Sino Biopharmaceutical Financial Overview

Sino Biopharmaceutical's market cap is currently HK$122.15B. The company's EPS TTM is HK$0.21003779616; its P/E ratio is 30.60; and it has a dividend yield of 1.40%. Sino Biopharmaceutical is scheduled to report earnings on August 18, 2025, and the estimated EPS forecast is HK$0.10. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 28.87B¥ 26.20B¥ 26.03B¥ 26.86B¥ 23.65B
Gross Profit¥ 23.53B¥ 21.21B¥ 21.54B¥ 21.53B¥ 18.46B
Operating Income¥ 6.14B¥ 5.79B¥ 5.59B¥ 5.08B¥ 4.19B
EBITDA¥ 6.11B¥ 6.98B¥ 6.69B¥ 19.87B¥ 5.66B
Net Income¥ 3.50B¥ 2.33B¥ 2.54B¥ 14.61B¥ 2.77B
Balance Sheet
Cash & Short-Term Investments¥ 14.60B¥ 14.12B¥ 16.92B¥ 15.79B¥ 16.43B
Total Assets¥ 65.41B¥ 63.60B¥ 64.06B¥ 60.54B¥ 47.21B
Total Debt¥ 9.78B¥ 12.58B¥ 13.98B¥ 12.12B¥ 14.21B
Net Debt¥ 214.26M¥ 3.13B¥ 5.33B¥ 2.52B¥ 3.59B
Total Liabilities¥ 22.63B¥ 25.43B¥ 26.12B¥ 22.81B¥ 24.79B
Stockholders' Equity¥ 31.96B¥ 30.47B¥ 29.75B¥ 30.29B¥ 16.75B
Cash Flow
Free Cash Flow¥ 5.22B¥ 4.36B¥ 4.56B¥ 3.47B¥ 3.47B
Operating Cash Flow¥ 6.62B¥ 6.07B¥ 6.27B¥ 5.37B¥ 5.33B
Investing Cash Flow¥ -1.71B¥ -756.98M¥ -4.07B¥ -2.52B¥ -7.85B
Financing Cash Flow¥ -6.32B¥ -6.55B¥ -3.19B¥ -3.23B¥ 2.23B
Currency in CNY

Sino Biopharmaceutical Earnings and Revenue History

Sino Biopharmaceutical Debt to Assets

Sino Biopharmaceutical Cash Flow

Sino Biopharmaceutical Forecast EPS vs Actual EPS